Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...

Here is what medical experts want everyone to know during the open enrollment period about changes to Medicare in 2026.

What if treatments or even cures for devastating rare diseases already existed — and were just waiting to be discovered? On ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage ...

Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at home—for a steep price. Full-face LED masks like this one can cost up to several ...

A new study from The University of Texas at Arlington has revealed how cells control their mitochondria—the "energy producers ...

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...

The Centers for Medicaid and Medicare (CMS) announced in January that its 2027 slate of 15 drugs for price negotiations would include weight loss drugs Ozempic, Rybelsus, and Wegovy.